open access

Vol 87, No 8 (2016)
Research paper
Published online: 2016-08-31
Get Citation

Assessment of clinicopathological features, evaluation of treatment, and prognosis of clear cell and serous papillary endometrial carcinoma

Mehmet Kulhan, Gozde Kulhan, Umit Nayki, Cenk Nayki, Pasa Ulug, Mehmet Sipahi, Yusuf Yildirim
·
Pubmed: 27629131
·
Ginekol Pol 2016;87(8):570-574.

open access

Vol 87, No 8 (2016)
ORIGINAL PAPERS Obstetrics
Published online: 2016-08-31

Abstract

Objectives: We aimed to evaluate and compare the clinical and pathological features, diagnosis, treatment, and prognosis of uterine papillary serous carcinoma (UPSC) and clear-cell carcinoma (CC).

Material and methods: Thirty-four patients who were operated on for UPSC and CC carcinoma at the İzmir Tepecik Research and Teaching Hospital, between January 1983 and December 2014, were included. Patients were evaluated for the following factors: age, gravidity, parity, preoperative CA-125, tumor size, myometrial and lymphovascular invasion, lymph node tumor metastasis, presence of atypical cells in peritoneal cytology, pathology results, operation types, whether or not they received postoperative adjuvant therapy, prognosis, and death rate.

Results: The stage of the disease was the main factor affecting disease-free and the overall survival. Cisplatin-based chemotherapy was partially effective in patients with postoperative recurrence, while postoperative adjuvant radiotherapy proved to be more effective in preventing relapse.

Conclusion: The studied parameters generally were concordant with the literature but, due to the relatively small sample size, more comprehensive and multicenter studies are needed to generate valid results.

Abstract

Objectives: We aimed to evaluate and compare the clinical and pathological features, diagnosis, treatment, and prognosis of uterine papillary serous carcinoma (UPSC) and clear-cell carcinoma (CC).

Material and methods: Thirty-four patients who were operated on for UPSC and CC carcinoma at the İzmir Tepecik Research and Teaching Hospital, between January 1983 and December 2014, were included. Patients were evaluated for the following factors: age, gravidity, parity, preoperative CA-125, tumor size, myometrial and lymphovascular invasion, lymph node tumor metastasis, presence of atypical cells in peritoneal cytology, pathology results, operation types, whether or not they received postoperative adjuvant therapy, prognosis, and death rate.

Results: The stage of the disease was the main factor affecting disease-free and the overall survival. Cisplatin-based chemotherapy was partially effective in patients with postoperative recurrence, while postoperative adjuvant radiotherapy proved to be more effective in preventing relapse.

Conclusion: The studied parameters generally were concordant with the literature but, due to the relatively small sample size, more comprehensive and multicenter studies are needed to generate valid results.

Get Citation

Keywords

endometrial tumors, clear-cell carcinoma, papillary cell carcinoma

About this article
Title

Assessment of clinicopathological features, evaluation of treatment, and prognosis of clear cell and serous papillary endometrial carcinoma

Journal

Ginekologia Polska

Issue

Vol 87, No 8 (2016)

Article type

Research paper

Pages

570-574

Published online

2016-08-31

Page views

1523

Article views/downloads

2045

DOI

10.5603/GP.2016.0046

Pubmed

27629131

Bibliographic record

Ginekol Pol 2016;87(8):570-574.

Keywords

endometrial tumors
clear-cell carcinoma
papillary cell carcinoma

Authors

Mehmet Kulhan
Gozde Kulhan
Umit Nayki
Cenk Nayki
Pasa Ulug
Mehmet Sipahi
Yusuf Yildirim

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl